| Dec'17 | Dec'16 | Dec'15 | Dec'14 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-118,550 | -351,807 | -225,753 | - | |||
Net loss | ||||||
- | - | - | -72,181 | |||
Depreciation of property and equipment | ||||||
10,099 | 9,579 | 4,329 | 1,751 | |||
Amortization of intangible assets | ||||||
23,069 | 20,893 | 8,924 | 158 | |||
Allowance for doubtful accounts | ||||||
7,041 | 4,453 | - | - | |||
Change in fair value of contingent consideration | ||||||
856 | -176 | - | - | |||
Foreign exchange loss | ||||||
-103 | -1,094 | -16,405 | - | |||
Foreign exchange (gain)/loss | ||||||
- | - | - | -439 | |||
Loss from disposal of property and equipment | ||||||
-86 | -124 | -32 | -9 | |||
Share-based compensation expenses | ||||||
15,166 | 13,310 | 10,056 | 6,313 | |||
Change in deferred tax liabilities | ||||||
-356 | -335 | -163 | - | |||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
9,881 | 11,063 | 11,497 | 1,127 | |||
Amounts due from related parties | ||||||
-43,635 | 56,925 | 9,165 | - | |||
Prepayments and other current assets | ||||||
-106,348 | 54,720 | 92,677 | 46,386 | |||
Accrued interests of yield enhancement products | ||||||
-2,323 | 4,223 | - | - | |||
Other non-current assets | ||||||
1,486 | -41,547 | 49,056 | 2,155 | |||
Accounts payable | ||||||
-25,708 | 11,345 | 49,477 | 13,601 | |||
Amounts due to related parties | ||||||
8,361 | 542 | 4,440 | - | |||
Salary and welfare payable | ||||||
-758 | 6,148 | - | - | |||
Taxes payable | ||||||
3,138 | -155 | 631 | 412 | |||
Advances from customers | ||||||
-91,584 | 104,931 | 82,178 | 39,017 | |||
Accrued expenses and other liabilities | ||||||
-33,970 | -57,483 | 132,377 | 16,451 | |||
Accrued interests of amounts due to the individual investors of yield enhancement products | ||||||
-1,719 | 1,161 | - | - | |||
Non-current liabilities | ||||||
-560 | -790 | - | - | |||
Net cash used in operating activities | ||||||
-64,347 | - | - | - | |||
Cash flows from investing activities: | ||||||
Net cash used in operating activities | ||||||
- | -322,550 | -79,462 | -43,693 | |||
Purchase of short-term investments | ||||||
382,400 | 734,165 | 175,938 | 88,253 | |||
Proceeds from maturity of short-term investments | ||||||
502,876 | 410,094 | 68,254 | 65,274 | |||
Purchase of yield enhancement products | ||||||
0 | 116,262 | 110,935 | - | |||
Proceeds from maturity of yield enhancement products | ||||||
66,855 | 77,558 | 1,677 | - | |||
Increase in loan receivable | ||||||
2,526 | - | - | - | |||
Increase in loan receivable | ||||||
- | 2,598 | - | - | |||
Changes in restricted cash | ||||||
-5,034 | -30,885 | 45,446 | 5,605 | |||
Purchase of property and equipment and intangible assets | ||||||
24,668 | 16,980 | 24,002 | 8,158 | |||
Cash paid for long-term investments | ||||||
65,510 | 8,282 | - | - | |||
Proceeds from disposal of property and equipment | ||||||
0 | 0 | 24 | 8 | |||
Cash paid for acquisition, net of cash received | ||||||
17 | 2,377 | 9,285 | - | |||
Net cash (used in)/provided by investing activities | ||||||
99,644 | - | - | - | |||
Cash flows from financing activities: | ||||||
Net cash used in investing activities | ||||||
- | -362,127 | -295,651 | -36,734 | |||
Proceeds from issuance of Series D Convertible Preferred Shares, net of issuance cost | ||||||
- | - | 0 | - | |||
Proceeds from the initial public offering, net of issuance cost | ||||||
- | 0 | 0 | 101,935 | |||
Proceeds from the private placement, net of issuance cost | ||||||
0 | 471,818 | 375,162 | 145,954 | |||
Cash paid for repurchase of ordinary shares | ||||||
25,537 | 2,839 | - | - | |||
Proceeds from issuance of ordinary shares upon exercise of options | ||||||
10,351 | 1,222 | 1,951 | 376 | |||
Contingent consideration paid for business acquisitions | ||||||
1,045 | 324 | - | - | |||
Acquisition of noncontrolling interests | ||||||
0 | - | - | - | |||
Cash contribution from noncontrolling interests | ||||||
553 | 12,963 | - | - | |||
Acquisition of noncontrolling interests | ||||||
- | 0 | 231 | - | |||
Proceeds from sales/(redemption) of yield enhancement products | ||||||
-104,938 | 39,565 | 89,456 | - | |||
Repayment of short-term debt | ||||||
0 | 0 | 2,316 | - | |||
Cash contribution from redeemable noncontrolling interest holders | ||||||
0 | - | - | - | |||
Net cash provided by financing activities | ||||||
- | 522,405 | 464,022 | - | |||
Net cash provided by/(used in) financing activities | ||||||
-120,616 | - | - | 248,266 | |||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-7,074 | 15,940 | 10,429 | -491 | |||
Net increase/(decrease) in cash and cash equivalents | ||||||
-92,393 | -146,332 | 99,338 | 167,346 | |||
Supplemental disclosure of cash flow information | ||||||
Income tax paid | ||||||
1,875 | - | - | - | |||
Income tax paid | ||||||
- | 217 | - | - | |||
Supplemental disclosure of non-cash investing and financing activities | ||||||
Accrual related to purchase of property and equipment | ||||||
1,823 | 2,443 | 2,926 | 1,506 | |||
Deemed dividends to preferred shareholders | ||||||
- | 0 | 0 | 2,515 | |||
Accrued issuance cost related to private placement | ||||||
- | 0 | 0 | 2,268 | |||
Accrual related to deferred initial public offering costs | ||||||
- | - | 0 | - | |||
Receivables related to exercise of stock options | ||||||
59 | 24 | 522 | 164 | |||
Accrual related to business acquisition | ||||||
5,858 | 5,667 | 6,502 | - | |||